Claudia Giani, MD

Medical Doctor
Fondazione IRCCS Istituto Nazionale Tumori, Italy

From September 2013 to September 2019 School of Medicine and Surgery, University of Milano-Bicocca: degree in Medicine and Surgery.
From August 2018 to October 2019 internship: Department of Pediatric Oncology, IRCCS Istituto Nazionale Tumori, Milan.
From 2020 attending Postgraduate School of Medical Oncology, IRCCS Istituto Nazionale Tumori, University of Milan.

Poster(s):

• (P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR

• (P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA

• (P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)

• (P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)